Page last updated: 2024-08-25

1,7-diaminoheptane and Breast Neoplasms

1,7-diaminoheptane has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, F; Fu, P; Hong, Y; Liu, R; Liu, Y; Yao, M; Zhang, X; Zheng, S	1

Other Studies

1 other study(ies) available for 1,7-diaminoheptane and Breast Neoplasms

Article	Year
N1-Guanyl-1,7-Diaminoheptane Sensitizes Estrogen Receptor Negative Breast Cancer Cells to Doxorubicin by Preventing Epithelial-Mesenchymal Transition through Inhibition of Eukaryotic Translation Initiation Factor 5A2 Activation. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 36, Issue:6 Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Diamines; Dose-Response Relationship, Drug; Doxorubicin; Epithelial-Mesenchymal Transition; Eukaryotic Translation Initiation Factor 5A; Female; Gene Knockdown Techniques; Humans; Peptide Initiation Factors; Receptors, Estrogen; RNA-Binding Proteins	2015

Article

Year

N1-Guanyl-1,7-Diaminoheptane Sensitizes Estrogen Receptor Negative Breast Cancer Cells to Doxorubicin by Preventing Epithelial-Mesenchymal Transition through Inhibition of Eukaryotic Translation Initiation Factor 5A2 Activation.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 36, Issue:6

Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Diamines; Dose-Response Relationship, Drug; Doxorubicin; Epithelial-Mesenchymal Transition; Eukaryotic Translation Initiation Factor 5A; Female; Gene Knockdown Techniques; Humans; Peptide Initiation Factors; Receptors, Estrogen; RNA-Binding Proteins

2015